Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource rightarrow Blocking Peptide rightarrow ASAH1  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • fucosyltransferase 11 (alpha (1, 3) fucosyltransferase) (fu... Antibody
 • Peptide Yy (PYY) ELISA Kit
 • Apolipoprotein H (APOH) ELISA Kit
 • Creatine Kinase, Mitochondrial 1A (CKMT1A) ELISA Kit
 • Non-canonical purine NTP pyrophosphatase (YPO0945, y3331, YP... Recombinant Protein
 • Interferon Regulatory Factor 3 (IRF3) Antibody
 • Nodulin-44 (LOC547903) Recombinant Protein
 • Anti-thyroid-globulin antibody (ATGA-TGAB) ELISA Kit
 • KISS1R Antibody
 • Aliphatic amidase (amiE) Recombinant Protein
 • Mammalian ependymin-related protein 1 (Epdr1) Recombinant Protein
 • Cytokeratin 13 (CK 13) ELISA Kit
 • Myogenic Differentiation Antigen (MYOD) ELISA Kit
 • Anti-Glycoprotein 210 Antibody (Anti-GP210) ELISA Kit
 downarrow more ...
separator
separator
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

ASAH1 blocking peptide

Scan QR to view Datasheet Catalog #    MBS152033 ASAH1 blocking peptide
Unit / Price
0.05 mg  /  $135 +1 FREE 8GB USB
 
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

ASAH1, Blocking Peptide

 Also Known As   

ASAH1 Peptide

 Product Synonym Names    AC; PHP; ASAH; PHP32; ACDase; SMAPME; HSD-33; HSD33; Acid ceramidase; Acylsphingosine deacylase; AC; N-acylsphingosine amidohydrolase (acid ceramidase) 1
 Product Gene Name   

ASAH1 blocking peptide

[Similar Products]
 Antibody/Peptide Pairs    ASAH1 peptide (MBS152033) is used for blocking the activity of ASAH1 antibody (MBS150694)
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 Western Blot Protocol    Western Blot Peptide Blocking Protocol
 OMIM    phenotype 613468
 3D Structure    ModBase 3D Structure for Q13510
Section Bar
Section Bar
 Form/Format    Liquid
 Concentration    200 ug/mL (lot specific)
Section Bar
 Species    Human
 Buffer    PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
 Location    16 amino acids near the carboxy terminus of human ASAH1
Section Bar
 Preparation and Storage    Store ASAH1 peptide at -20 degree C, stable for one year.
 Other Notes    Small volumes of ASAH1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar
 Applications Tested/Suitable for ASAH1 blocking peptide   

Blocking (BL)

 Application Notes for ASAH1 blocking peptide    ASAH1 peptide is used for blocking the activity of ASAH1 antibody.
Table BarTOPTable Bar
NCBI/Uniprot data below describe general gene information for ASAH1. It may not necessarily be applicable to this product.
 NCBI GI #    119584199
 NCBI GeneID    427
 NCBI Accession #    EAW63795 [Other Products]
Section Bar
 UniProt Primary Accession #    Q13510 [Other Products]
 UniProt Secondary Accession #    Q6W898; Q96AS2; E9PDS0 [Other Products]
 UniProt Related Accession #    Q13510 [Other Products]
 Molecular Weight    44,046 Da
Table BarTOPTable Bar
 NCBI Official Full Name    N-acylsphingosine amidohydrolase (acid ceramidase) 1, isoform CRA_c
 NCBI Official Synonym Full Names    N-acylsphingosine amidohydrolase (acid ceramidase) 1
 NCBI Official Symbol    ASAH1 [Similar Products]
 NCBI Official Synonym Symbols   
AC; PHP; ASAH; PHP32; ACDase; SMAPME
[Similar Products]
 NCBI Protein Information    acid ceramidase; acid CDase; acylsphingosine deacylase; putative 32 kDa heart protein
 UniProt Protein Name    Acid ceramidase
 UniProt Synonym Protein Names   
Acylsphingosine deacylase; N-acylsphingosine amidohydrolase; Putative 32 kDa heart protein; PHP32
 Protein Family    Acid ceramidase
 UniProt Gene Name    ASAH1 [Similar Products]
 UniProt Synonym Gene Names    ASAH; AC; ACDase; Acid CDase; PHP32 [Similar Products]
 UniProt Entry Name    ASAH1_HUMAN
Section Bar
 NCBI Summary for ASAH1    This gene encodes a heterodimeric protein consisting of a nonglycosylated alpha subunit and a glycosylated beta subunit that is cleaved to the mature enzyme posttranslationally. The encoded protein catalyzes the synthesis and degradation of ceramide into sphingosine and fatty acid. Mutations in this gene have been associated with a lysosomal storage disorder known as Farber disease. Multiple transcript variants encoding several distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Section Bar
 UniProt Comments for ASAH1    ASAH1: Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid. Defects in ASAH1 are the cause of Farber lipogranulomatosis (FL); also known as Farber disease (FD). This sphingolipid disease is characterized by subcutaneous lipid-loaded nodules, excruciating pain in the joints and extremities, marked accumulation of ceramide in lysosomes, and death by three years of age. Defects in ASAH1 are the cause of spinal muscular atrophy with progressive myoclonic epilepsy (SMAPME). An autosomal recessive neuromuscular disorder characterized by childhood onset of motor deficits and progressive myoclonic seizures, after normal developmental milestones. Proximal muscle weakness and generalized muscular atrophy are due to degeneration of spinal motor neurons. Myoclonic epilepsy is generally resistant to conventional therapy. The disease course is progressive and leads to respiratory muscle involvement and severe handicap or early death from respiratory insufficiency. Belongs to the acid ceramidase family. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Hydrolase; Lipid Metabolism - sphingolipid; EC 3.5.1.23

Chromosomal Location of Human Ortholog: 8p22

Cellular Component: lysosomal lumen

Molecular Function: ceramidase activity; catalytic activity

Biological Process: response to organic substance; sphingolipid metabolic process; glycosphingolipid metabolic process; ceramide metabolic process; lung development

Disease: Farber Lipogranulomatosis
Table BarTOPTable Bar
 Research Articles on ASAH1    1. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with ASAH1 blocking peptidePathways associated with ASAH1 blocking peptide
 Reference Product  PubMed Publications
 SMPD1 blocking peptide  >62 publications with ASAH1 and SMPD1
 SPHK1 blocking peptide  >3 publications with ASAH1 and SPHK1
 GALC blocking peptide  >2 publications with ASAH1 and GALC
 UGCG blocking peptide  >1 publications with ASAH1 and UGCG
 SPHK2 blocking peptide  >1 publications with ASAH1 and SPHK2
 SGPP1 blocking peptide  >1 publications with ASAH1 and SGPP1
 Products by Pathway  Pathway Diagram
 Ceramide Signaling Pathway antibodies  Ceramide Signaling Pathway Diagram
 Glycosphingolipid Metabolism Pathway antibodies  Glycosphingolipid Metabolism Pathway Diagram
 Lysosome Pathway antibodies  Lysosome Pathway Diagram
 Lysosome Pathway antibodies  Lysosome Pathway Diagram
 Metabolic Pathways antibodies  Metabolic Pathways Diagram
 Metabolism Pathway antibodies  Metabolism Pathway Diagram
 Metabolism Of Lipids And Lipoproteins Pathway antibodies  Metabolism Of Lipids And Lipoproteins Pathway Diagram
 Signal Transduction Of S1P Receptor Pathway antibodies  Signal Transduction Of S1P Receptor Pathway Diagram
 Sphingolipid Metabolism Pathway antibodies  Sphingolipid Metabolism Pathway Diagram
 Sphingolipid Metabolism Pathway antibodies  Sphingolipid Metabolism Pathway Diagram
Diseases associated with ASAH1 blocking peptideOrgans/Tissues associated with ASAH1 blocking peptide
 Disease Name  Pubmed Publications
 Lipidoses Antibodies  >29 publications with ASAH1 and Lipidoses
 Farber Lipogranulomatosis Antibodies  >27 publications with ASAH1 and Farber Lipogranulomatosis
 Necrosis Antibodies  >15 publications with ASAH1 and Necrosis
 Liver Diseases Antibodies  >11 publications with ASAH1 and Liver Diseases
 Inflammation Antibodies  >8 publications with ASAH1 and Inflammation
 Fatty Liver Antibodies  >8 publications with ASAH1 and Fatty Liver
 Fibrosis Antibodies  >6 publications with ASAH1 and Fibrosis
 Drug-Induced Liver Injury Antibodies  >4 publications with ASAH1 and Drug-Induced Liver Injury
 Kidney Diseases Antibodies  >4 publications with ASAH1 and Kidney Diseases
 Seizures Antibodies  >4 publications with ASAH1 and Seizures
 Organ/Tissue Name  Pubmed Publications
 Skin Antibodies  >41 publications with ASAH1 and Skin
 Liver Antibodies  >35 publications with ASAH1 and Liver
 Blood Antibodies  >31 publications with ASAH1 and Blood
 Brain Antibodies  >31 publications with ASAH1 and Brain
 Kidney Antibodies  >24 publications with ASAH1 and Kidney
 Lung Antibodies  >22 publications with ASAH1 and Lung
 Prostate Antibodies  >18 publications with ASAH1 and Prostate
 Muscle Antibodies  >18 publications with ASAH1 and Muscle
 Intestine Antibodies  >10 publications with ASAH1 and Intestine
 Vascular Antibodies  >9 publications with ASAH1 and Vascular
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions